English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52611601    Online Users :  952
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"hsu c h"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 471-495 of 1656  (67 Page(s) Totally)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-03-19T01:54:19Z Early alpha-foetoprotein response associated with treatment efficacy of immune checkpoint inhibitors for advanced hepatocellular carcinoma Shao Y.-Y.; TSUNG-HAO LIU; Hsu C.; Lu L.-C.; Shen Y.-C.; Lin Z.-Z.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-19T01:54:19Z Differential Organ-Specific Tumor Response to Immune Checkpoint Inhibitors in Hepatocellular Carcinoma Lu L.-C.; Hsu C.; Shao Y.-Y.; Chao Y.; Yen C.-J.; Shih I.-L.; Hung Y.-P.; Chang C.-J.; Shen Y.-C.; Guo J.-C.; TSUNG-HAO LIU; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2021-03-19T01:54:17Z It takes two to tango: breakthrough advanced hepatocellular carcinoma treatment that combines anti-angiogenesis and immune checkpoint blockade TSUNG-HAO LIU; Shao Y.-Y.; Hsu C.-H.
臺大學術典藏 2021-03-18T08:54:37Z Comparative study between endoscopic ultrasonography and positron emission tomography-computed tomography in staging patients with esophageal squamous cell carcinoma Yen T.-J.; Chung C.-S.; YEN-WEN WU; Yen R.-F.; Cheng M.-F.; Lee J.-M.; Hsu C.-H.; Chang Y.-L.; Wang H.-P.
臺大學術典藏 2021-03-18T08:54:23Z TSOC-HFrEF registry: A registry of hospitalized patients with decompensated systolic heart failure: Description of population and management Wang C.-C.; Chang H.-Y.; Yin W.-H.; YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Lin W.-S.; Huang J.-L.; Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J.
臺大學術典藏 2021-03-18T08:54:21Z The Obesity-Mortality Paradox in Patients With Heart Failure in Taiwan and a Collaborative Meta-Analysis for East Asian Patients Lin G.-M.; Li Y.-H.; Yin W.-H.; YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Wang C.-C.; Yeh S.-J.; Lin W.-S.; Chan K.-C.; Chang H.-C.; Chang K.-C.; Chen Z.-C.; Chen S.-M.; Chu P.-H.; Hsu C.-H.; Huang J.-L.; Kuo J.Y.; Lin J.-L.; Lin W.-S.; Mar G.-Y.; Shyu K.-G.; Sung S.-H.; Tseng W.-K.; Voon W.-C.; Wang J.-H.; Wen M.-S.; Yang N.-I.
臺大學術典藏 2021-03-18T08:54:18Z One-year outcomes of acute decompensated systolic heart failure in Taiwan: Lessons from TSOC-HFreF registry Chang H.-Y.; Wang C.-C.; YEN-WEN WU; Chu P.-H.; Wu C.-C.; Hsu C.-H.; Wen M.-S.; Voon W.-C.; Lin W.-S.; Huang J.-L.; Chen S.-M.; Yang N.-I.; Chang H.-C.; Chang K.-C.; Sung S.-H.; Shyu K.-G.; Lin J.-L.; Mar G.-Y.; Chan K.-C.; Kuo J.-Y.; Wang J.-H.; Chen Z.-C.; Tseng W.-K.; Cherng W.-J.; Yin W.-H.
臺大學術典藏 2021-03-18T05:58:55Z Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma Huang T.-C.; Lin C.-C.; Wu Y.-C.; Chia-Hsien Cheng J.; Lee J.-M.; Wang H.-P.; Huang P.-M.; Hsu F.-M.; Yeh K.-H.; Cheng A.-L.; KAI-YUAN TZEN; Hsu C.-H.
臺大學術典藏 2021-03-18T03:23:38Z Prognostic factors of metastatic or recurrent esophageal squamous cell carcinoma in patients receiving three-drug combination chemotherapy WEI-WU CHEN; Lin C.-C.; Huang T.-C.; Cheng A.-L.; Yeh K.-H.; Hsu C.-H.
臺大學術典藏 2021-03-18T03:23:30Z A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors Lee J.-H.; WEI-WU CHEN; Hsu C.-H.; Yen Y.-H.; Yang J.C.-H.; Cheng A.-L.; Sasaki S.-I.; Chiu L.Y.; Sugihara M.; Ishizuka T.; Oguma T.; Tajima N.; Lin C.-C.
臺大學術典藏 2021-03-18T02:03:00Z Disseminated peritoneal leiomyomatosis responds to systemic chemotherapy Lin Y.-C.; Wei L.-H.; CHIA-TUNG SHUN; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-18T02:02:53Z Polymorphism in epidermal growth factor receptor intron 1 predicts prognosis of patients with esophageal cancer after chemoradiation and surgery Lee J.-M.;Yang S.-Y.;Yang P.-W.;Chia-Tung Shun;Wu M.-T.;Hsu C.-H.;Lin C.-C.;Cheng J.-C.-H.;Wang Y.-H.;Chuang T.-H.;Chen J.-S.;Hsu H.-H.;Huang P.-M.;Kuo S.-W.;Lee Y.-C.; Lee J.-M.; Yang S.-Y.; Yang P.-W.; CHIA-TUNG SHUN; Wu M.-T.; Hsu C.-H.; Lin C.-C.; Cheng J.-C.-H.; Wang Y.-H.; Chuang T.-H.; Chen J.-S.; Hsu H.-H.; Huang P.-M.; Kuo S.-W.; Lee Y.-C.
臺大學術典藏 2021-03-18T02:02:48Z Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: A multicenter phase II study Hsu C.-H.;Kang Y.K.;Yang T.-S.;Chia-Tung Shun;Shao Y.-Y.;Su W.-C.;Sandoval-Tan J.;Chiou T.-J.;Jin K.;Hsu C.;Cheng A.-L.; Hsu C.-H.; Kang Y.K.; Yang T.-S.; CHIA-TUNG SHUN; Shao Y.-Y.; Su W.-C.; Sandoval-Tan J.; Chiou T.-J.; Jin K.; Hsu C.; Cheng A.-L.
臺大學術典藏 2021-03-18T02:02:23Z Increased Expression of Programmed Death-Ligand 1 in Infiltrating Immune Cells in Hepatocellular Carcinoma Tissues after Sorafenib Treatment Lu L.-C.;Lee Y.-H.;Chang C.-J.;Chia-Tung Shun;Fang C.-Y.;Shao Y.-Y.;Liu T.-H.;Cheng A.-L.;Hsu C.-H.; Lu L.-C.; Lee Y.-H.; Chang C.-J.; CHIA-TUNG SHUN; Fang C.-Y.; Shao Y.-Y.; Liu T.-H.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-15T08:26:16Z AlGaN/GaN high electron mobility transistors for protein-peptide binding affinity study Huang C.-C.; Lee G.-Y.; Chyi J.-I.; HUI-TENG CHENG; Hsu C.-P.; Hsu Y.-R.; Hsu C.-H.; Huang Y.-F.; Sun Y.-C.; Chen C.-C.; Li S.-S.; Andrew Yeh J.; Yao D.-J.; Ren F.; Wang Y.-L.
臺大學術典藏 2021-03-15T07:44:49Z Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer LI-CHUN LU; Shao Y.-Y.; Hsu C.-H.; Hsu C.; Cheng W.-F.; Lin Y.-L.; Cheng A.-L.; Yeh K.-H.
臺大學術典藏 2021-03-15T07:44:49Z Increasing incidence of brain metastasis in patients with advanced Hepatocellular carcinoma in the era of Antiangiogenic targeted therapy Shao Y.-Y.; LI-CHUN LU; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-15T07:44:49Z Prognosis of advanced hepatocellular carcinoma patients enrolled in clinical trials can be classified by current staging systems Shao Y.-Y.; LI-CHUN LU; Lin Z.-Z.; Hsu C.; Shen Y.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2021-03-15T07:44:48Z �]-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma LI-CHUN LU; Shao Y.-Y.; Lee Y.-H.; Hsieh M.-S.; Hsiao C.-H.; Lin H.-H.; Kao H.-F.; Ma Y.-Y.; Yen F.-C.; Cheng A.-L.; Hsu C.-H.
臺大學術典藏 2021-03-15T07:44:48Z Hospital volume of percutaneous radiofrequency ablation is closely associated with treatment outcomes for patients with hepatocellular carcinoma LI-CHUN LU; Shao Y.-Y.; Kuo R.N.C.; Lin Z.-Z.; Yeh Y.-C.; Shau W.-Y.; Hsu C.-H.; Cheng A.-L.; Lai M.-S.
臺大學術典藏 2021-03-15T07:44:47Z Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy Shao Y.-Y.; Wu C.-H.; LI-CHUN LU; Chan S.-Y.; Ma Y.-Y.; Yen F.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2021-03-15T07:44:47Z Clinical characteristics of advanced hepatocellular carcinoma patients with prolonged survival in the era of anti-angiogenic targeted-therapy LI-CHUN LU; Shao Y.-Y.; Chan S.-Y.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2021-03-15T07:44:46Z Tumor heterogeneity in hepatocellular carcinoma: Facing the challenges LI-CHUN LU; Hsu C.-H.; Hsu C.; Cheng A.-L.
臺大學術典藏 2021-03-15T07:44:46Z Tumor-associated neutrophils: An emerging player in the immune microenvironment of hepatocellular carcinoma LI-CHUN LU; Hsu C.-H.
臺大學術典藏 2021-03-15T07:44:46Z Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials Shao Y.-Y.; Shau W.-Y.; Chan S.-Y.; LI-CHUN LU; Hsu C.-H.; Cheng A.-L.

Showing items 471-495 of 1656  (67 Page(s) Totally)
<< < 14 15 16 17 18 19 20 21 22 23 > >>
View [10|25|50] records per page